Small molecules of different origins have distinct distributions of structural complexity that correlate with protein-binding profiles

被引:251
作者
Clemons, Paul A. [1 ]
Bodycombe, Nicole E. [1 ]
Carrinski, Hyman A. [1 ]
Wilson, J. Anthony [1 ]
Shamji, Alykhan F. [1 ]
Wagner, Bridget K. [1 ]
Koehler, Angela N. [1 ]
Schreiber, Stuart L. [1 ,2 ,3 ]
机构
[1] Harvard & MIT, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA
[2] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA
[3] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA
基金
美国国家卫生研究院;
关键词
chemical diversity; cheminformatics; natural products; small-molecule microarrays; small-molecule probes; NATURAL-PRODUCTS; DISCOVERY; DRUGS; IMPACT; SMILES;
D O I
10.1073/pnas.1012741107
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Using a diverse collection of small molecules generated from a variety of sources, we measured protein-binding activities of each individual compound against each of 100 diverse (sequence-unrelated) proteins using small-molecule microarrays. We also analyzed structural features, including complexity, of the small molecules. We found that compounds from different sources (commercial, academic, natural) have different protein-binding behaviors and that these behaviors correlate with general trends in stereochemical and shape descriptors for these compound collections. Increasing the content of sp(3)-hybridized and stereogenic atoms relative to compounds from commercial sources, which comprise the majority of current screening collections, improved binding selectivity and frequency. The results suggest structural features that synthetic chemists can target when synthesizing screening collections for biological discovery. Because binding proteins selectively can be a key feature of high-value probes and drugs, synthesizing compounds having features identified in this study may result in improved performance of screening collections.
引用
收藏
页码:18787 / 18792
页数:6
相关论文
共 33 条
[1]   Discovery of chemical reactions through multidimensional screening [J].
Beeler, Aaron B. ;
Su, Shun ;
Singleton, Chris A. ;
Porco, John A., Jr. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (05) :1413-1419
[2]   The properties of known drugs .1. Molecular frameworks [J].
Bemis, GW ;
Murcko, MA .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (15) :2887-2893
[3]   A robust small-molecule microarray platform for screening cell lysates [J].
Bradner, James E. ;
McPherson, Olivia M. ;
Mazitschek, Ralph ;
Barnes-Seeman, David ;
Shen, John P. ;
Dhaliwal, Jasmeet ;
Stevenson, Kristen E. ;
Duffner, Jay L. ;
Park, Seung Bum ;
Neuberg, Donna S. ;
Nghiem, Paul ;
Schreiber, Stuart L. ;
Koehler, Angela N. .
CHEMISTRY & BIOLOGY, 2006, 13 (05) :493-504
[4]  
COREY EJ, 1989, LOGIC CHEM SYNTHESIS, P436
[5]   Distinct Biological Network Properties between the Targets of Natural Products and Disease Genes [J].
Dancik, Vlado ;
Seiler, Kathleen Petri ;
Young, Damian W. ;
Schreiber, Stuart L. ;
Clemons, Paul A. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2010, 132 (27) :9259-9261
[6]   A pipeline for ligand discovery using small-molecule microarrays [J].
Duffner, Jay L. ;
Clemons, Paul A. ;
Koehler, Angela N. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2007, 11 (01) :74-82
[7]  
Ertl Peter, 2008, V66
[8]   Property distributions: Differences between drugs, natural products, and molecules from combinatorial chemistry [J].
Feher, M ;
Schmidt, JM .
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2003, 43 (01) :218-227
[9]   ANALYSIS OF STRUCTURE-ACTIVITY RELATIONSHIP OF SULFONAMIDE DRUGS USING SUBSTITUENT CONSTANTS [J].
FUJITA, T ;
HANSCH, C .
JOURNAL OF MEDICINAL CHEMISTRY, 1967, 10 (06) :991-&
[10]   The impact of natural products upon modern drug discovery [J].
Ganesan, A. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2008, 12 (03) :306-317